These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1565470)

  • 1. Amplification of 11q13 DNA sequences in human breast cancer: D11S97 identifies a region tightly linked to BCL1 which can be amplified separately.
    Szepetowski P; Courseaux A; Carle GF; Theillet C; Gaudray P
    Oncogene; 1992 Apr; 7(4):751-5. PubMed ID: 1565470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification at chromosome 11q13 in transitional cell tumours of the bladder.
    Proctor AJ; Coombs LM; Cairns JP; Knowles MA
    Oncogene; 1991 May; 6(5):789-95. PubMed ID: 2052357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D11S146 and BCL1 are physically linked but can be discriminated by their amplification status in human breast cancer.
    Szepetowski P; Nguyen C; Perucca-Lostanlen D; Carle GF; Tsujimoto Y; Birnbaum D; Theillet C; Gaudray P
    Genomics; 1991 Jun; 10(2):410-6. PubMed ID: 2071147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA amplification at 11q13.5-q14 in human breast cancer.
    Szepetowski P; Ollendorff V; Grosgeorge J; Courseaux A; Birnbaum D; Theillet C; Gaudray P
    Oncogene; 1992 Dec; 7(12):2513-7. PubMed ID: 1461654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCND1 and FGFR1 coamplification results in the colocalization of 11q13 and 8p12 sequences in breast tumor nuclei.
    Bautista S; Theillet C
    Genes Chromosomes Cancer; 1998 Aug; 22(4):268-77. PubMed ID: 9669664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer.
    Schuuring E; Verhoeven E; van Tinteren H; Peterse JL; Nunnink B; Thunnissen FB; Devilee P; Cornelisse CJ; van de Vijver MJ; Mooi WJ
    Cancer Res; 1992 Oct; 52(19):5229-34. PubMed ID: 1394126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
    Gaffey MJ; Frierson HF; Williams ME
    Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL-1 participates in the 11q13 amplification found in breast cancer.
    Theillet C; Adnane J; Szepetowski P; Simon MP; Jeanteur P; Birnbaum D; Gaudray P
    Oncogene; 1990 Jan; 5(1):147-9. PubMed ID: 2181375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas.
    Schuuring E; Verhoeven E; Mooi WJ; Michalides RJ
    Oncogene; 1992 Feb; 7(2):355-61. PubMed ID: 1532244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1.
    Lammie GA; Fantl V; Smith R; Schuuring E; Brookes S; Michalides R; Dickson C; Arnold A; Peters G
    Oncogene; 1991 Mar; 6(3):439-44. PubMed ID: 2011398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
    Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
    Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A region within murine chromosome 7F4, syntenic to the human 11q13 amplicon, is frequently amplified in 4NQO-induced oral cavity tumors.
    Yuan B; Oechsli MN; Hendler FJ
    Oncogene; 1997 Sep; 15(10):1161-70. PubMed ID: 9294609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer.
    Hui R; Campbell DH; Lee CS; McCaul K; Horsfall DJ; Musgrove EA; Daly RJ; Seshadri R; Sutherland RL
    Oncogene; 1997 Sep; 15(13):1617-23. PubMed ID: 9380415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails the bcl-1, int-2 and hst loci.
    Ali IU; Merlo G; Callahan R; Lidereau R
    Oncogene; 1989 Jan; 4(1):89-92. PubMed ID: 2915903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.
    Zukerberg LR; Yang WI; Gadd M; Thor AD; Koerner FC; Schmidt EV; Arnold A
    Mod Pathol; 1995 Jun; 8(5):560-7. PubMed ID: 7675778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification.
    Bringuier PP; Tamimi Y; Schuuring E; Schalken J
    Oncogene; 1996 Apr; 12(8):1747-53. PubMed ID: 8622895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GST pi gene is frequently coamplified with INT2 and HSTF1 proto-oncogenes in human breast cancers.
    Saint-Ruf C; Malfoy B; Scholl S; Zafrani B; Dutrillaux B
    Oncogene; 1991 Mar; 6(3):403-6. PubMed ID: 1826346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome 11q13 abnormalities in human breast cancer.
    Fantl V; Smith R; Brookes S; Dickson C; Peters G
    Cancer Surv; 1993; 18():77-94. PubMed ID: 8013002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
    Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP
    Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line.
    Lebwohl DE; Muise-Helmericks R; Sepp-Lorenzino L; Serve S; Timaul M; Bol R; Borgen P; Rosen N
    Oncogene; 1994 Jul; 9(7):1925-9. PubMed ID: 8208539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.